Global Oncology Molecular Diagnostics Market Overview And Top Key Players by 2030
The Oncology Molecular Diagnostics Global Market Report 2021-30 by The Business Research Company describes and explains the global oncology molecular diagnostics market and covers 2015 to 2020, termed the historic period, and 2020 to 2025, termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.
The Oncology Molecular Diagnostics Global Market Report 2021 covers oncology
molecular diagnostics market drivers, oncology molecular diagnostics market
trends, oncology molecular diagnostics market segments, oncology molecular
diagnostics market growth rate, oncology molecular diagnostics market major
players, and oncology molecular diagnostics market size.
View Complete Report:
The oncology molecular diagnostics market report provides an in-depth
analysis of the impact of COVID-19 on the global oncology molecular diagnostics
industry, along with revised market numbers due to the effects of the
coronavirus and the expected oncology molecular diagnostics market growth
numbers 2021-2030.
Oncology Molecular Diagnostics Global Market Report 2021 is the most
comprehensive report available on this market and will help gain a truly global
perspective as it covers 60 geographies. The chapter on the impact of COVID-19
gives valuable insights on supply chain disruptions, logistical challenges, and
other economic implications of the virus on the market. The chapter also covers
markets which have been positively affected by the pandemic.
Request For The Sample
Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3457&type=smp
The global oncology molecular diagnostics market is expected to grow
from $5.59 billion in 2020 to $6.25 billion in 2021 at a compound annual growth
rate (CAGR) of 11.8%. The growth is mainly due to the companies resuming their
operations and adapting to the new normal while recovering from the COVID-19
impact, which had earlier led to restrictive containment measures involving
social distancing, remote working, and the closure of commercial activities
that resulted in operational challenges. The oncology molecular diagnostics
market is expected to reach $9.56 billion in 2025 at a CAGR of 11%.
The report covers the oncology
molecular diagnostics market segments-
1) By Product: Instruments, Reagents, Others
2) By Technology: Polymerase Chain Reaction
(PCR), In-situ Hybridization (ISH), Isothermic Nucleic Acid Amplification
Technology (INNAT), Chips & Microarrays, Sequencing, Mass Spectroscopy,
Transcription Mediated Amplification (TMA), Others
3) By End User: Hospitals, Diagnostic Centers, Academic & Research
Institutes, Others
About The Business Research Company:
The Business
Research Company is a market intelligence firm that excels in company, market,
and consumer research. Located globally it has specialist consultants in a wide
range of industries including manufacturing, healthcare, financial services,
chemicals, and technology. It has offices in the UK, the US and India and
a network of trained researchers in 20+ countries globally.
Contact
Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315
623 0293
Email: info@tbrc.info
Follow us on LinkedIn:
https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter:
https://twitter.com/tbrc_info
Comments
Post a Comment